Mometasonfuroat Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroat Glenmark, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions, particularly in adult and pediatric patients with inflammatory skin disorders.

GNH USA supplies Mometasonfuroat Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mometasone furoate is a topical glucocorticoid indicated for several inflammatory skin disorders. - Psoriasis: reduces plaque formation and scaling by suppressing local immune response. - Atopic dermatitis: alleviates itching and erythema through anti‑inflammatory action. - Eczema: improves lesion appearance and discomfort by limiting cytokine release. - Seborrheic dermatitis: controls flaking and redness by decreasing sebaceous gland inflammation.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Dryness or peeling of the skin. - Mild itching or pruritus.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Secondary skin infections (bacterial, fungal, or viral).

When using Mometasonfuroat Glenmark, follow these safety considerations. - Application area: limit to affected skin and avoid large surface coverage. - Duration: use for the shortest period necessary; discontinue if condition improves. - Occlusion: avoid covering treated area with dressings unless directed. - Age restrictions: consult pediatric guidelines; avoid use in infants unless prescribed. - Systemic absorption: monitor for signs of adrenal suppression with extensive use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Mometasone furoate may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Concurrent use with potent CYP3A4 inhibitors may increase systemic exposure. - Systemic corticosteroids: additive risk of hypothalamic‑pituitary‑adrenal suppression. - Antifungal agents (e.g., ketoconazole) applied to the same area: may enhance local potency.

Moderate Interactions (Monitor Closely): - Topical NSAIDs: may increase irritation risk. - Skin barrier disruptors (e.g., retinoids): monitor for increased absorption. - Live vaccines: efficacy may be reduced if systemic absorption occurs.